Who owns SPRUCE BIOSCIENCES INC?
- Ticker: SPRB
- CUSIP Number: 85209e109
Tip: Access positions for across all investors
Analyze quarterly positions in Spruce Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spruce Biosciences stock
Who bought or sold SPRUCE BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RiverVest Venture Management | 2.9M | $2.3B | 0% | Mar 2024 |
|
| Carlyle | 2.9M | $2.3M | 0% | Mar 2024 |
|
| Rock Springs Capital Management | 2.6M | $2.1M | -4% | Mar 2024 |
|
| Omega Fund Management | 2.2M | $6.3M | 0% | Dec 2023 |
|
| Rosalind Advisors | 1.5M | $1.2M | -5% | Mar 2024 |
|
| Aisling Capital Management | 1.2M | $3.5M | 0% | Dec 2023 |
|
| Altium Capital Management | 1.2M | $904k | 100% | Mar 2024 |
|
| Vanguard Group | 863k | $679k | 5% | Mar 2024 |
|
| Sands Capital Ventures | 787k | $622k | 0% | Mar 2024 |
|
| Superstring Capital Management | 440k | $346k | 271% | Mar 2024 |
|
| Acadian Asset Management | 369k | $289k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 365k | $287k | 100% | Mar 2024 |
|
| PanAgora Asset Management | 254k | $199k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 225k | $177k | 100% | Mar 2024 |
|
| Geode Capital Management | 200k | $157k | 20% | Mar 2024 |
|
| AWM Investment Company | 200k | $157k | 100% | Mar 2024 |
|
| BlackRock | 186k | $146k | -28% | Mar 2024 |
|
| Walleye Trading Advisors | 179k | $141k | 100% | Mar 2024 |
|
| Two Sigma Investments | 123k | $97k | -8% | Mar 2024 |
|
| Citadel Advisors | 121k | $95k | 12% | Mar 2024 |
|
| Millennium Management | 102k | $80k | -80% | Mar 2024 |
|
| Two Sigma Advisers | 90k | $71k | -6% | Mar 2024 |
|
| Bridgeway Capital Management | 85k | $67k | 0% | Mar 2024 |
|
| Jane Street | 79k | $62k | 100% | Mar 2024 |
|
| Lion Point Capital | 75k | $59k | 100% | Mar 2024 |
|
| Northern Trust | 75k | $59k | 54% | Mar 2024 |
|
| Marshall Wace | 72k | $57k | -32% | Mar 2024 |
|
| Castleview Partners | 60k | $47k | 100% | Mar 2024 |
|
| XTX Topco | 57k | $45k | 100% | Mar 2024 |
|
| Belvedere Trading | 50k | $39k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 47k | $37k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 40k | $28k | 100% | Mar 2024 |
|
| Caption Management | 39k | $31k | 100% | Mar 2024 |
|
| Susquehanna International | 30k | $23k | 100% | Mar 2024 |
|
| Simplex Trading | 28k | $22k | 100% | Mar 2024 |
|
| Bank of America Corporation | 26k | $21k | 200900% | Mar 2024 |
|
| Two Sigma Securities | 26k | $20k | 100% | Mar 2024 |
|
| Privium Fund Management | 25k | $20k | 0% | Mar 2024 |
|
| Balyasny Asset Management | 23k | $18k | 100% | Mar 2024 |
|
| Morgan Stanley | 22k | $17k | 910% | Mar 2024 |
|
| UBS Group | 16k | $12k | 3161% | Mar 2024 |
|
| Charles Schwab Investment Management | 15k | $12k | 0% | Mar 2024 |
|
| Tower Research Capital | 11k | $9.0k | 162% | Mar 2024 |
|
| Group One Trading | 3.9k | $3.1k | 100% | Mar 2024 |
|
| Caldwell Sutter Capital | 1.0k | $786.000000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 143.00 | $111.997600 | 1% | Mar 2024 |
|
| FMR | 103.00 | $80.999200 | 186% | Mar 2024 |
|
| Jpmorgan Chase & Co | 11.00 | $9.000200 | 0% | Mar 2024 |
|
Who sold out of Spruce Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2023 | 3.1M | $6.9M |
| 5AM Venture Management | Dec 2023 | 2.4M | $6.9M |
| AIGH Capital Management | Dec 2023 | 2.1M | $6.2M |
| Verition Fund Management | Sep 2023 | 1.3M | $3.0M |
| DAFNA Capital Management | Dec 2023 | 549k | $1.6M |
| Worth Venture Partners | Dec 2023 | 527k | $1.5M |
| Alyeska Investment Group | Dec 2023 | 400k | $1.2M |
| Acuitas Investments | Dec 2023 | 275k | $806k |
| Sofinnova Ventures | Sep 2023 | 58k | $131k |
| Marquette Asset Management | Dec 2023 | 56k | $163k |
| Royal Bank of Canada | Dec 2023 | 8.9k | $25k |